AVEO Pharmaceuticals Inc

  All amounts in Millions of US Dollars except per share items
Select start date for quarterly reports
BALANCE SHEET (at a glance)
2014/032014/062014/092014/122015/03
INDICATORS
quarter end date2014/032014/062014/092014/122015/03
date preliminary data loaded2015-04-182015-06-272015-06-272015-06-272015-05-16
earnings period indicatorAAAAA
quarterly indicator12341
basic earnings indicatorYYYYY
template indicator
preliminary full context indNNNNN
projected fiscal year date2014-12-312014-12-312014-12-312014-12-312015-12-31
number of months last report period33333
INCOME STATEMENT
operating revenue15.31.80.90.10.1
total revenue15.31.80.90.10.1
adjustments to revenue0.00.00.00.00.0
cost of sales0.00.00.00.00.0
cost of sales with depreciation0.00.00.00.00.0
gross margin15.31.80.90.10.1
gross operating profit15.31.80.90.10.1
Research & Development (R&D) Expense11.89.38.58.72.7
Selling, General & Administrative (SG&A) Expense5.64.85.13.13.3
advertising0.00.00.00.00.0
operating income-5.9-17.5-14.1-13.0-10.1
EBITDA-5.0-16.6-12.9-9.6-5.7
depreciation0.00.00.00.00.0
depreciation (unrecognized)-0.8-0.9-1.1-3.5-4.5
amortization0.80.91.13.54.5
amortization of intangibles0.00.00.00.00.0
operating profit after depreciation-5.0-16.6-12.9-9.6-5.7
interest income0.00.00.00.00.0
earnings from equity interest0.00.00.00.00.0
other income net0.0-0.00.1-0.0-0.0
income, acquired in process r&a0.00.00.00.00.0
Income, Restructuring and M&A0.00.00.00.00.0
other special charges0.00.00.00.00.0
special income charges-3.9-5.2-1.4-1.3-4.3
EBIT-5.9-17.5-14.0-13.0-10.2
interest expense0.60.50.40.90.7
pre-tax income -6.5-18.0-14.4-13.9-10.9
income taxes0.00.00.00.00.0
minority interest0.00.00.00.00.0
pref. securities of subsid. trust0.00.00.00.00.0
income before income taxes-6.5-18.0-14.4-13.9-10.9
net income (continuing operations)-6.5-18.0-14.4-13.9-10.9
net income (discontinued operations)0.00.00.00.00.0
net income (total operations)-6.5-18.0-14.4-13.9-10.9
extraordinary income/losses0.00.00.00.00.0
income from cum. effect of acct. change0.00.00.00.00.0
income from tax loss carryforward0.00.00.00.00.0
other gains/losses0.00.00.00.00.0
total net income-6.5-18.0-14.4-13.9-10.9
normalized income-2.6-12.8-13.0-12.6-6.5
net income available for common-6.5-18.0-14.4-13.9-10.9
preferred dividends0.00.00.00.00.0
excise taxes0.00.00.00.00.0
*
Basic EPS (Continuing)-0.12-0.35-0.28-0.26-0.21
Basic EPS (Discontinued)0.000.000.000.000.00
Basic EPS from Total Operations-0.12-0.35-0.28-0.26-0.21
Basic EPS (Extraordinary Items)0.000.000.000.000.00
Basic EPS (Cum. Effect of Acct. Change)0.000.000.000.000.00
Basic EPS (Tax Loss Carry Forward)0.000.000.000.000.00
Basic EPS (Other Gains/Losses)0.000.000.000.000.00
Basic EPS - Total-0.12-0.35-0.28-0.26-0.21
Basic EPS - Normalized-0.05-0.25-0.25-0.23-0.12
*
Diluted EPS (Continuing)-0.12-0.35-0.28-0.26-0.21
Diluted EPS (Discontinued)0.000.000.000.000.00
Diluted EPS from Total Operations-0.12-0.35-0.28-0.26-0.21
Diluted EPS (Extraordinary)0.000.000.000.000.00
Diluted EPS (Cum. Effect of Acct. Change)0.000.000.000.000.00
Diluted EPS (Tax Loss Carry Forward)0.000.000.000.000.00
Diluted EPS (Other Gains/Losses)0.000.000.000.000.00
Diluted EPS - Total-0.12-0.35-0.28-0.26-0.21
Diluted EPS - Normalized-0.05-0.25-0.25-0.23-0.12
Dividends Paid Per Share (DPS)0.000.000.000.000.00
INCOME STATEMENT (YEAR-TO-DATE)
Revenue (YTD)15.317.118.018.10.1
Net Income from Total Operations (YTD)-6.5-24.4-38.8-52.7-10.9
EPS from Total Operations (YTD)-0.12-0.47-0.75-1.01-0.21
Dividends Paid Per Share (YTD)0.000.000.000.000.00
BALANCE SHEET
ASSETS
cash & equivalents46.343.460.052.334.5
restricted cash0.60.73.03.03.0
marketable securities88.364.963.452.339.1
accounts receivable1.31.21.72.30.9
loans receivable0.00.00.00.00.0
other receivable13.314.90.20.00.0
receivables14.616.11.92.30.9
inventories, raw materials0.00.00.00.00.0
inventories, work in progress0.00.00.00.00.0
inventories, purchased components0.00.00.00.00.0
inventories, finished goods0.00.00.00.00.0
inventories, other0.00.00.00.00.0
inventories, adjustments & allowances0.00.00.00.00.0
inventories0.00.00.00.00.0
prepaid expenses2.03.73.31.51.4
current defered income taxes0.00.00.00.00.0
other current assets0.00.00.00.00.0
total current assets105.685.471.559.144.4
land and improvements0.00.00.00.00.0
building and improvements0.00.00.00.00.0
machinery, furniture & equipment0.00.00.012.50.0
construction in progress0.00.00.00.00.0
other fixed assets19.015.914.711.35.4
total fixed assets19.015.914.711.35.4
gross fixed assets19.015.914.711.35.4
accumulated depreciation0.00.00.0-15.60.0
net fixed assets19.015.914.711.35.4
intangibles0.00.00.00.00.0
cost in excess0.00.00.00.00.0
non-current deferred income taxes0.00.00.00.00.0
other non-current assets3.23.00.00.20.2
total non-current assets22.218.814.711.55.6
total assets127.8104.286.270.750.0
inventory valuation methodNoNoNo
EQUITY & LIABILITIES
accounts payable4.03.51.73.22.6
notes payable0.00.00.00.00.0
short-term debt-2.50.00.00.00.0
accrued expenses12.416.27.19.36.4
accrued liabilities0.00.00.00.00.0
deferred revenues2.91.10.30.50.5
current deferred income taxes0.00.00.00.00.0
other current liabilities0.00.00.00.00.0
total current liabilities32.633.038.940.426.6
long-term debt6.03.112.58.98.1
capital lease obligations0.00.00.00.00.0
deferred income taxes0.00.00.00.00.0
other non-current liabilities3.57.60.50.50.7
minority interest liability63.557.352.050.135.4
preferred secur. of subsid. trust0.00.00.00.00.0
preferred equity outside stock equity0.00.00.00.00.0
total non-current liabilities30.924.313.19.78.9
total liabilities63.557.352.050.135.4
preferred stock equity0.00.00.00.00.0
common stock equity64.347.034.320.614.6
common par0.00.00.00.00.0
additional paid-in capital497.9498.6500.4500.6505.4
cumulative translation adjustments0.00.00.00.00.0
retained earnings-433.7-451.7-466.1-480.0-490.9
treasury stock0.00.00.00.00.0
other equity adjustments0.00.00.00.00.0
total capitalization70.350.046.829.522.7
total equity64.347.034.320.614.6
total liabilities & stock equity127.8104.286.270.750.0
*
cash flow0.00.00.00.00.0
working capital72.952.432.618.817.9
free cash flow-27.6-19.5-9.0-11.1-15.8
invested capital81.061.154.741.332.6
*
shares out (common class only)52.352.352.252.30.0
preferred shares0.00.00.00.00.0
total ordinary shares52.352.352.252.355.0
total common shares out52.352.352.252.355.0
treasury shares0.00.00.00.00.0
basic weighted shares0.00.00.00.00.0
diluted weighted shares0.00.00.00.00.0
number of employees575757
number of part-time employees
CASH-FLOW STATEMENT
OPERATING ACTIVITIES
net income/loss-6.5-18.0-14.4-13.9-10.9
depreciation0.00.00.00.00.0
amortization0.80.91.13.54.5
amortization of intangibles0.00.00.00.00.0
deferred income taxes0.00.00.00.00.0
operating gains0.00.0-0.1-0.0-0.0
extraordinary gains0.00.00.00.00.0
(increase) decrease in receivables-7.8-1.614.3-0.51.4
(increase) decrease in inventories0.00.00.00.00.0
(increase) decrease in prepaid expenses1.0-1.60.41.80.3
(increase) decrease in other current assets0.00.00.00.00.0
decrease (increase) in payables-1.60.9-1.81.6-0.6
decrease (increase) in other current liabilities0.13.7-8.02.2-2.9
decrease (increase) in other working capital-9.2-5.6-0.6-11.1-0.1
other non-cash items3.45.91.30.41.0
net cash from continuing operations-19.8-15.4-8.0-11.0-15.8
net cash from discontinued operations0.00.00.00.00.0
net cash from total operating activities-19.8-15.4-8.0-11.0-15.8
INVESTING ACTIVITIES
sale of property, plant & equipment0.00.00.00.00.9
sale of long-term investments0.00.00.00.00.0
sale of short-term investments58.625.318.17.71.5
purchase of property, plant & equipment-7.8-4.1-1.0-0.10.0
acquisitions0.00.00.00.00.0
purchase of long-term investments0.00.00.00.00.0
purchase of short-term investments-33.1-5.00.0-4.3-6.0
other investing changes, net0.00.00.00.00.0
cash from discontinued investing activities0.00.00.00.00.0
net cash from investing activities17.816.317.33.4-3.6
FINANCING ACTIVITIES
issuance of debt0.00.00.00.00.0
issuance of capital stock0.00.00.00.24.4
repayment of long-term debt0.00.0-1.40.0-2.8
repurchase of capital stock0.00.00.00.00.0
payment of cash dividends0.00.00.00.00.0
other financing charges, net0.00.00.00.00.0
cash from discontinued financing activities0.00.00.00.00.0
net cash from financing activities-2.5-3.87.30.01.7
NET CASH FLOW
effect exchange rate changes0.00.00.00.00.0
net change in cash & equivalents-4.5-3.016.6-7.7-17.8
cash at beginning of period50.846.343.460.052.3
cash end of period46.343.460.052.334.5
*
foreign sales0.00.00.00.00.0
domestic sales0.00.00.00.00.0
auditor nameErnst & Young LLPErnst & Young LLPErnst & Young LLP
auditor reportUQUQUQ
RATIOS CALCULATIONS
PROFIT MARGINS
Close PE Ratio0.00.00.00.0-1.1
High PE Ratio0.00.00.00.0-19.8
Low PE Ratio0.00.00.00.0-0.6
gross profit margin1.01.01.01.00.0
pre-tax profit margin0.00.00.00.00.0
post-tax profit margin0.00.00.00.00.0
net profit margin-0.2-0.9-1.6-108.50.0
interest coverage (cont. operations)-10.1-21.5-24.5-15.00.0
interest as % of invested capital0.00.00.00.00.0
effective tax rate0.00.00.00.00.0
income per employee
NORMALIZED RATIOS
Normalized Close PE Ratio0.00.00.00.00.0
Normalized High PE Ratio0.00.00.00.00.0
Normalized Low PE Ratio0.00.00.00.00.0
normalized net profit margin-0.2-0.9-1.6-108.50.0
Normalized ROE0.00.00.00.00.0
Normalized ROA0.00.00.00.00.0
Normalized ROCI0.00.00.00.00.0
normalized income per employee
SOLVENCY RATIOS
quick ratio3.22.51.71.40.0
current ratio3.22.61.81.50.0
payout ratio
total debt/equity ratio0.260.300.601.000.00
long-term debt/total capital 0.090.060.270.300.00
EFFICIENCY RATIOS
leverage ratio0.30.30.61.00.0
asset turnover0.10.00.00.00.0
cash as % of revenue303.12349.06870.645091.425772.4
receivables as % of revenue95.3874.1212.42018.1706.7
SG&A as % of Revenue36.3262.5582.42675.92429.1
R&D as % of Revenue77.0503.8971.97501.72011.2
ACTIVITY RATIOS
revenue per $ cash0.330.040.010.000.00
revenue per $ plant (net)0.800.120.060.010.02
revenue per $ common equity0.240.040.030.010.01
revenue per $ invested capital0.190.030.020.000.00
LIQUIDITY RATIOS
receivables turnover13.71.50.60.10.0
inventory turnover0.00.00.00.00.0
receivables per day sales2182351.45262284.6612262.321488.350.00
sales per $ receivables0.000.000.000.000.00
sales per $ inventory0.000.000.000.000.00
revenue/assets0.10.00.00.00.0
number of days cost of goods in inventory
current assets per share0.000.000.000.000.84
total assets per share0.000.000.000.000.94
intangibles as % of book-value0.00.00.00.00.0
inventory as % of revenue0.00.00.00.00.0
CAPITAL STRUCTURE RATIOS
long-term debt per share0.000.000.000.000.15
current liabilities per share0.000.000.000.000.50
cash per share0.000.000.000.00-0.96
LT-Debt to Equity Ratio0.090.070.360.430.00
LT-Debt as % of Invested Capital7.45.122.821.625.0
LT-Debt as % of Total Debt35.921.861.143.245.2
total debt as % total assets13.113.623.729.236.0
working captial as % of equity113.5111.695.291.1122.4
revenue per share0.000.000.000.000.00
book value per share0.000.000.000.000.27
tangible book value per share0.000.000.000.000.28
price/revenue ratio511.035184.976643.3437873.460.00
price/equity ratio121.58203.83169.23213.210.00
price/tangible book ratio121.58203.83169.23213.210.00
working capital as % of price93.354.856.242.70.0
PROFITABILITY
working capital per share1.401.000.620.360.00
cash flow per share-0.38-0.29-0.15-0.21-0.96
free cash flow per share-0.53-0.37-0.17-0.21-1.06
Return on Stock Equity (ROE)-0.1-0.3-0.4-0.50.0
Return on Capital Invested (ROCI)0.00.00.00.00.0
Return on Assets (ROA)0.0-0.2-0.2-0.20.0
price/cash flow ratio0.00.00.00.0-1.2
price/free cash flow ratio0.00.00.00.0-1.1
sales per employee2153382413382536202035
AGAINST THE INDUSTRY RATIOS
% of sales-to-industry
% of earnings-to-industry
% of EPS-to-Industry
% of price-to-industry
% of PE-to-Industry
% of price/book-to-industry
% of price/sales-to-industry
% of price/cashflow-to-industry
% of pric/free cashlow-to-industry
% of debt/equity-to-industry
% of current ratio-to-industry
% of gross profit margin-to-industry
% of pre-tax profit margin-to-industry
% of post-tax profit margin-to-industry
% of net profit margin-to-industry
% of ROE-to-Industry
% of leverage-to-industry


Your Recent History
NASDAQ
AVEO
Aveo Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.